InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) EBT (2016 - 2026)

InflaRx's (IFRX) quarterly EBT came in at -$7.3 million in Q2 2026, up 48.08% year-over-year from -$4.9 million in Q2 2025, and up 9.3% quarter-over-quarter from -$8.0 million in Q1 2026.

Analysis

InflaRx (IFRX) EBT (2016 - 2026) Analysis & Trends

InflaRx has disclosed EBT across 11 years of filings, most recently posting -$7.3 million for Q2 2026.

  • In Q2 2026, EBT rose 48.08% year-over-year to -$7.3 million; the TTM figure through Jun 2026 stood at -$40.4 million (up 59.28% YoY), while the FY2025 annual figure was -$51.5 million, down 4.72% from the prior year.
  • EBT came in at -$7.3 million for Q2 2026 at InflaRx, up from -$8.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $621.0 billion in Q4 2022 to a low of -$55.9 million in Q4 2024.
  • Average EBT over 5 years is $34.5 billion, with a median of -$11.7 million recorded in 2023.
  • Year-over-year, EBT jumped 396.44% in 2022 and slumped 797.68% in 2023.
  • Over 5 years, EBT stood at $621.0 billion in 2022, then sank by 100.01% to -$47.1 million in 2023, then decreased by 18.62% to -$55.9 million in 2024, then soared by 74.07% to -$14.5 million in 2025, then surged by 49.75% to -$7.3 million in 2026.
  • Per Business Quant data, the three most recent EBT figures were -$7.3 million in Q2 2026, -$8.0 million in Q1 2026, and -$14.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.77 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.25 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.39 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 542.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -767.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 177.81 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 132.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -294.56 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -7.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.28 Mn
Mar 31, 2026 -8.03 Mn
Dec 31, 2025 -14.49 Mn
Sep 30, 2025 -10.55 Mn
Jun 30, 2025 -14.03 Mn
Mar 31, 2025 -13.16 Mn
Dec 31, 2024 -55.90 Mn
Sep 30, 2024 -16.02 Mn
Jun 30, 2024 -15.66 Mn
Mar 31, 2024 -12.58 Mn
Dec 31, 2023 -47.13 Mn
Sep 30, 2023 -10.84 Mn
Jun 30, 2023 -9.54 Mn
Mar 31, 2023 -10.88 Mn
Dec 31, 2022 620.97 Bn
Sep 30, 2022 -8.46 Mn
Jun 30, 2022 -1.06 Mn
Mar 31, 2022 -16.62 Mn
Dec 31, 2021 125.09 Bn
Sep 30, 2021 -14.97 Mn